Other Non-Current Assets - Narrative (Details) $ in Millions |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Oct. 31, 2024
USD ($)
|
Oct. 31, 2023
USD ($)
|
Dec. 31, 2021
€ / shares
shares
|
|
| AgomAb Therapeutics NV | Preferred class C shares | |||
| Financial instruments and financial risk management | |||
| Proceeds from issue of shares | $ 100 | ||
| AgomAb Therapeutics NV | Preferred class D shares | |||
| Financial instruments and financial risk management | |||
| Proceeds from issue of shares | $ 89 | ||
| Zai Lab | |||
| Financial instruments and financial risk management | |||
| Number of shares issued (in shares) | shares | 568,182 | ||
| Share price (in EUR per share) | € / shares | € 132 | ||